Claims for Patent: 9,808,465

Summary for Patent: 9,808,465

Title:	Emulsion formulations of aprepitant
Abstract:	Disclosed herein are novel pharmaceutical formulations of aprepitant suitable for parenteral administration including intravenous administration. Also included are formulations including both aprepitant and dexamethasone sodium phosphate. The pharmaceutical formulations are stable oil-in-water emulsions for non-oral treatment of emesis and are particularly useful for treatment of subjects undergoing highly emetogenic cancer chemotherapy.
Inventor(s):	Ottoboni; Thomas B. (Belmont, CA), Han; Han (Mountain View, CA)
Assignee:	Heron Therapeutics, Inc. (Redwood City, CA)
Application Number:	14/859,013
Patent Litigation and PTAB cases:	See patent lawsuits and PTAB cases for patent 9,808,465
Patent Claims:	1. A method for preventing or treating a subject at risk of or suffering from emesis, comprising administering to the subject a composition comprising an injectable physically stable emulsion wherein the emulsion comprises: aprepitant; 11 wt/wt % to 15 wt/wt % of an emulsifier; an oil; a co-emulsifier which is an alcohol; a tonicity modifier; a pH modifier; and water; wherein the ratio of emulsifier:aprepitant ranges from about 18:1 to 22:1, and wherein the pH of the emulsion ranges from about 7.5 to 9.0. 2. The method according to claim 1, wherein the emesis is induced by chemotherapy. 3. The method according to claim 1, wherein the emesis is induced by highly emetogenic chemotherapy. 4. The method according to claim 1, wherein the ratio of the oil to the aprepitant within the oil phase of the emulsion ranges from about 10:1 to 15:1 (wt/wt %). 5. The method according to claim 1, wherein the ratio of the emulsifier to the oil ranges from about 1:1 to 3:1 (wt/wt %). 6. The method according to claim 5, wherein the emulsifier in the emulsion is a phospholipid. 7. The method according to claim 1, wherein the emulsion further comprises dexamethasone sodium phosphate, wherein the dexamethasone sodium phosphate is present in the aqueous phase. 8. The method according to claim 1, wherein the emulsifier in the emulsion is an egg lecithin. 9. The method according to claim 1, wherein the pH modifier in the emulsion is sodium oleate. 10. The method according to claim 1, wherein the emulsion further comprises a buffer. 11. The method according to claim 10, wherein the buffer is Tris buffer. 12. The method according to claim 1, wherein the oil in the emulsion is soybean oil. 13. The method according to claim 1, wherein the alcohol in the emulsion is ethanol. 14. The method according to claim 13, wherein the ethanol is present in the emulsion at less than 10 wt/wt %. 15. The method according to claim 13, wherein the tonicity modifier in the emulsion is sucrose.